Daniel N Mills

US Patent:

52371590, Aug 17, 1993

Filed:

Jul 17, 1991

Appl. No.:

7/731529

Inventors:

Thomas S. Stephens - Addison TX
George B. Anderson - Freehold NJ
Daniel R. Mills - Los Angeles CA
Richard A. Sherman - Marlboro NJ
Harry B. Drollinger - McKinney TX

Assignee:

J. D. Carreker and Associates - Dallas TX

International Classification:

G06F 1530

US Classification:

235379

Abstract:

An Electronic Check Presentment System provides a bank with a fully automated capability for participating in the electronic exchange of check data. It allows banks that utilize the system to take MICR data that has been obtained through check capture methods, selectively extract particular check records and place them in the form of electronic cash letters, transfer the electronic cash letters to selected banks, receive electronic cash letters from other banks, reconcile the electronic cash letters against the paper cash letters when they arrive, and input the electronic MICR data into a database responsible for maintaining check records.

US Patent:

20190054468, Feb 21, 2019

Filed:

Oct 21, 2016

Appl. No.:

15/770413

Inventors:

- Charlottesville VA, US
Kimberly Renee JACKSON - Atlanta GA, US
Daniel MILLS - Charlottesville VA, US
Gavin T. GARNER - Charlottesville VA, US
Jacquelyn A. DuVall - Raleigh NC, US
Jingyi LI - Charlottesville VA, US

International Classification:

B01L 3/00
C12Q 1/6809
C12Q 1/6816
C12Q 1/6827
G01N 33/52
G01N 33/543
G01N 33/68
G01N 35/00

Abstract:

This disclosure provides for apparatuses, systems and methods for in vitro sample detection. For example in one embodiment, this disclosure provides an automated Pe-toner microfluidic device (and related method) on a centrifugal platform for DNA sample lysis and DNA extraction. A second embodiment provides a system and method for qualitative detection, quantification, and real-time monitoring of nucleic acid amplification products using magnetic bead aggregation inhibition. A third embodiment provides a platform for simultaneous detection of mRNA markers from blood, cell-free semen, sperm, saliva, and vaginal fluid. The third embodiment comprises a system and method that provide for simple, rapid, and fluorescence-free detection of body fluids using mRNA marker amplification and optical detection for mRNA marker analysis with a smart phone with image analysis.